title: Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.
abstract: Duloxetine is a serotonin-norepinephrine reuptake inhibitor which is generally safe and well tolerated. Antidepressants especially selective serotonin reuptake inhibitors (SSRIs) were associated with inducing bruxism; however, duloxetine-induced bruxism has not been reported yet. Here, we report a case of duloxetine-induced bruxism in a patient with generalized anxiety disorder.
authors.affiliation: Department of Psychiatry, Gölbaşı Havsak State Hospital, Ankara, Turkey. dr.fuge@hotmail.com
authors.forename: Yakup
authors.initials: Y
authors.lastname: Albayrak
authors.forename: Okan
authors.initials: O
authors.lastname: Ekinci
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects; D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone / Q000627:therapeutic use*; D016903:Drug Monitoring; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D020258:Neurotoxicity Syndromes / Q000503:physiopathology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000502:physiology; D044282:Receptor, Serotonin, 5-HT1A / Q000737:chemistry; D058825:Serotonin 5-HT1 Receptor Agonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D020186:Sleep Bruxism / Q000139:chemically induced* / Q000188:drug therapy / Q000209:etiology; D013876:Thiophenes / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D014151:Anti-Anxiety Agents; D002065:Buspirone; D000068736:Duloxetine Hydrochloride; D009638:Norepinephrine; D044282:Receptor, Serotonin, 5-HT1A; D058825:Serotonin 5-HT1 Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes